Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ceftriaxone (500mg) + Sulbactam (250mg)
Therapeutic Category
Antibacterials, Antibiotic, Dermatology, Gastroenterology, General and OTC medicines, Pulmonary, Respiratory, Urology
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
Mono
Price
₹91/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
What are the business opportunities for Ceftriaxone 500mg + Sulbactam 250mg Injection in the PCD pharma franchise market?Fritcet S 750 Injection is a powerful combination antibiotic used to treat a wide range of bacterial infections. Ceftriaxone, a third-generation cephalosporin, works by disrupting bacterial cell wall synthesis, leading to the death of the bacteria. Sulbactam, a beta-lactamase inhibitor, enhances the efficacy of Ceftriaxone by preventing bacterial resistance through enzyme inhibition. This combination is particularly effective against beta-lactamase-producing bacteria, which are resistant to many standard antibiotics.
Fritcet S 750 is commonly indicated for infections of the respiratory tract, urinary tract, skin and soft tissues, intra-abdominal infections, and septicemia. It is also used in certain cases of meningitis and prophylaxis in surgical procedures. Its broad-spectrum activity makes it a vital choice for tackling complex infections.
The injectable form ensures rapid absorption and immediate action, providing fast relief from severe bacterial infections.
Common side effects may include pain or swelling at the injection site, diarrhea, nausea, or headache. Rarely, allergic reactions, changes in liver enzymes, or blood disorders may occur.
Effective in treating bacterial infections of the respiratory tract, urinary tract, skin, soft tissues, and intra-abdominal infections.
Use under medical supervision. Avoid if allergic to cephalosporins or penicillins. Complete the full course to prevent antibiotic resistance.
Store below 25°C, protected from light. Do not freeze. Keep out of reach of children.
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Clindamycin (300mg) Injection
Composition : Clindamycin (600mg)
Composition : Colistimethate Sodium (1Million IU)
Composition : Colistimethate Sodium (2Million IU)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ceftriaxone 500mg + Sulbactam 250mg Injection has strong demand in the hospital, anti-infective, and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotics and institutional healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for moderate to severe bacterial infection management under medical supervision. Ceftriaxone 500mg is a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity Sulbactam 250mg is a beta-lactamase inhibitor that enhances the effectiveness of ceftriaxone against resistant bacterial strains Commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, gynecological infections, and other susceptible bacterial infections Widely used in hospitals, nursing homes, and critical care settings Injectable formulation provides rapid and effective treatment for serious infections This strengthens a robust anti-infective and hospital-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ceftriaxone 500mg + Sulbactam 250mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, repeat orders, reliable supply chain support, high market acceptance, and attractive margins in the injectable antibiotic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.